Legal & General Group’s Maravai LifeSciences MRVI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $26.9K | Sell |
11,149
-111,244
| -91% | -$268K | ﹤0.01% | 2889 |
|
|
2025
Q1 | $270K | Hold |
122,393
| – | – | ﹤0.01% | 2565 |
|
|
2024
Q4 | $667K | Sell |
122,393
-179
| -0.1% | -$976 | ﹤0.01% | 2365 |
|
|
2024
Q3 | $1.02M | Buy |
122,572
+333
| +0.3% | +$2.77K | ﹤0.01% | 2228 |
|
|
2024
Q2 | $875K | Buy |
122,239
+9,692
| +9% | +$69.4K | ﹤0.01% | 2238 |
|
|
2024
Q1 | $976K | Sell |
112,547
-516
| -0.5% | -$4.47K | ﹤0.01% | 2199 |
|
|
2023
Q4 | $741K | Hold |
113,063
| – | – | ﹤0.01% | 2310 |
|
|
2023
Q3 | $1.13M | Buy |
113,063
+5,260
| +5% | +$52.6K | ﹤0.01% | 2143 |
|
|
2023
Q2 | $1.34M | Sell |
107,803
-2,898
| -3% | -$36K | ﹤0.01% | 2092 |
|
|
2023
Q1 | $1.55M | Buy |
110,701
+7,304
| +7% | +$102K | ﹤0.01% | 1991 |
|
|
2022
Q4 | $1.48M | Buy |
103,397
+2,255
| +2% | +$32.3K | ﹤0.01% | 2007 |
|
|
2022
Q3 | $2.58M | Sell |
101,142
-4,849
| -5% | -$124K | ﹤0.01% | 1726 |
|
|
2022
Q2 | $3.01M | Buy |
105,991
+6,465
| +6% | +$184K | ﹤0.01% | 1675 |
|
|
2022
Q1 | $3.51M | Buy |
99,526
+611
| +0.6% | +$21.5K | ﹤0.01% | 1712 |
|
|
2021
Q4 | $4.14M | Buy |
98,915
+8,002
| +9% | +$335K | ﹤0.01% | 1675 |
|
|
2021
Q3 | $4.46M | Buy |
90,913
+42,957
| +90% | +$2.11M | ﹤0.01% | 1613 |
|
|
2021
Q2 | $2M | Buy |
47,956
+39,567
| +472% | +$1.65M | ﹤0.01% | 1973 |
|
|
2021
Q1 | $299K | Sell |
8,389
-10,653
| -56% | -$380K | ﹤0.01% | 2380 |
|
|
2020
Q4 | $533K | Buy |
+19,042
| New | +$533K | ﹤0.01% | 2247 |
|